Page 300«..1020..299300301302..310320..»

Fulcrum Therapeutics Reports Recent Business Highlights and Third Quarter 2021 Financial Results – The Bakersfield Californian

Posted: Published on November 5th, 2021

On-track to initiate enrollment by year-end in Phase 1b clinical trial of FTX-6058 in people with sickle cell disease Losmapimod update planned for Q1 2022 Raised $144.2 million in gross proceeds from August 2021 public offering, extendingcash runway into 2024 Conference call scheduled for 8:00 a.m. ET today CAMBRIDGE, Mass., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. Continue reading

Posted in Muscular Dystrophy Treatment | Comments Off on Fulcrum Therapeutics Reports Recent Business Highlights and Third Quarter 2021 Financial Results – The Bakersfield Californian

Elizabeth M. McNally, M.D., Ph.D., FAHA, named the American Heart Association’s 2021 Distinguished Scientist in Basic Cardiovascular Sciences -…

Posted: Published on November 5th, 2021

Embargoed until 7 a.m. CT / 8 a.m Continue reading

Posted in Muscular Dystrophy Treatment | Comments Off on Elizabeth M. McNally, M.D., Ph.D., FAHA, named the American Heart Association’s 2021 Distinguished Scientist in Basic Cardiovascular Sciences -…

Why Sarepta Therapeutics Shares Dropped More Than 16% This Week – Motley Fool

Posted: Published on November 5th, 2021

Key Points Shares in Sarepeta Therapeutics (NASDAQ:SRPT) fell more than 16% this week, according to data from S&P Global Market Intelligence. The stock closed last Friday at $448.68 then fell to as low as $376.26 on Wednesday, a day after the company reported earnings Continue reading

Posted in Muscular Dystrophy Treatment | Comments Off on Why Sarepta Therapeutics Shares Dropped More Than 16% This Week – Motley Fool

Clyde W. Yancy, M.D., M.Sc., FAHA, of Northwestern University to receive the American Heart Association’s 2021 Chairman’s Award – EurekAlert

Posted: Published on November 5th, 2021

Embargoed until 7 a.m. Continue reading

Posted in Clinical Cardiology | Comments Off on Clyde W. Yancy, M.D., M.Sc., FAHA, of Northwestern University to receive the American Heart Association’s 2021 Chairman’s Award – EurekAlert

The benefits of the ABCD classification system for heart disease – DVM 360

Posted: Published on November 5th, 2021

The importance of diagnosing pets in the pre-clinical phase of heart disease, plus the advantages of the classification system. Although veterinarians are often skilled at diagnosing pets with clinical heart failure, it is critical they are skilled at diagnosing those with pre-clinical heart disease as well, according to Amara Estrada, DVM, DACVIM(Cardiology), professor of cardiology at the University of Florida. This proactive approach positively impacts patients by enhancing their quality of life and ultimately helping to delay the disease's development. Continue reading

Posted in Clinical Cardiology | Comments Off on The benefits of the ABCD classification system for heart disease – DVM 360

Drs. Kiran Musunuru and Katey Rayner to be recognized with the American Heart Association’s 2021 Joseph A. Vita Award – EurekAlert

Posted: Published on November 5th, 2021

Embargoed until 7 a.m. Continue reading

Posted in Clinical Cardiology | Comments Off on Drs. Kiran Musunuru and Katey Rayner to be recognized with the American Heart Association’s 2021 Joseph A. Vita Award – EurekAlert

The Fundamentals of QTc: Understanding Risks and Preventing Problems – Psychiatric Times

Posted: Published on November 5th, 2021

Some psychiatric medications that can trigger Torsades de Pointes (TdP), a potentially fatal polymorphic ventricular tachycardia that arises during abnormal ventricular repolarization. Are you aware of the risk factors that increase risk of TdP Continue reading

Posted in Clinical Cardiology | Comments Off on The Fundamentals of QTc: Understanding Risks and Preventing Problems – Psychiatric Times

TCT 2021: Philips announces new innovations and clinical data supporting the treatment of patients with cardiovascular disease – Yahoo Finance

Posted: Published on November 5th, 2021

Philips Interventional Applications Platform IntraSight Mobile Philips Laser System Nexcimer Philips Scoring Balloon Catheter RX AngioSculpt Evo Philips Image Guided Therapy System Azurion November 2, 2021 Philips debuts three new solutions in the North American market that will help drive procedural innovation and workflow efficiency, adding to the companys ecosystem of interventional imaging systems, and diagnostic and therapeutic devices New clinical data presented at TCT 2021: five-year outcomes of iFR-SWEDEHEART trial and new large-scale analysis of Centers for Medicare & Medicaid Services (CMS) data on use of Intravascular Ultrasound (IVUS) in diagnosing and treating peripheral vascular disease Amsterdam, the Netherlands Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced North American availability of new innovations in its portfolio of cardiology solutions designed to seamlessly work together, strengthen clinical confidence, build efficiency throughout the care pathway, and improve cardiac care outcomes and experiences. The new updates, aimed at innovating and advancing procedures including percutaneous coronary intervention (PCI) to treat the narrowing of coronary arteries, are being announced at the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting (Orlando, USA, November 4-6). Continue reading

Posted in Clinical Cardiology | Comments Off on TCT 2021: Philips announces new innovations and clinical data supporting the treatment of patients with cardiovascular disease – Yahoo Finance

UAB researchers determine that using genes to guide medication regimens after getting a heart stent improves outcomes – News – The Mix

Posted: Published on November 5th, 2021

A study conducted by UAB researchers found that using genetic information for choosing medical treatment after getting a heart stent reduces the risk of potentially fatal cardiovascular events. Vibhu Parcha, M.D., and Pankaj Arora, M.D.A recent study published inCirculation: Genomic and Precision Medicinefound that using genetic information to prescribe medications following a stents being placed after a heart attack reduces the risk of fatal outcomes in the future. Continue reading

Posted in Clinical Cardiology | Comments Off on UAB researchers determine that using genes to guide medication regimens after getting a heart stent improves outcomes – News – The Mix

Diversity in Cardiology | Department of Medicine News – Stanford Medicine

Posted: Published on November 5th, 2021

Clarke and Tcheandjieu met in Assimes lab, and they started collaborating almost immediately. Shoa is very much interested in the same research questions that Im interested in, Tcheandjieu explains, How can we improve genomic research for underrepresented minorities and create some precision medicine tool that is also applicable to those individuals Continue reading

Posted in Clinical Cardiology | Comments Off on Diversity in Cardiology | Department of Medicine News – Stanford Medicine

Page 300«..1020..299300301302..310320..»